

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.83%
-9.70%
+2.50%
+3.16%
-8.72%
NUTX
Nutex Health
$127.69
Strengths

Earnings are forecast to grow

Expands stock buyback program
Chart
$102.53 (+24.54%)
$85.58 (+49.21%)
$148.14 (-13.80%)
$27.17 (+369.97%)
NUTX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Low volume

High volatilty

NUTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating
Momentum
Momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
NUTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NUTX Street view is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayNUTX Earnings
The TTM reflects 12-month period, providing review of NUTX financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is NUTX current stock price?
What are NUTX stock strengths?
What risks are associated with NUTX stock?
When is NUTX next earnings report?
What is NUTX market cap and volume?
What is NUTX's current Stock IQ?
Should I buy NUTX stock right now?
Is NUTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for NUTX?
What does a 'Strong Sell' rating mean for NUTX?
What factors influence NUTX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.83%
-9.70%
+2.50%
+3.16%
-8.72%
NUTX
Nutex Health
Current Price
$127.69
Stock Insights
Strengths

Earnings are forecast to grow

Expands stock buyback program
Chart
$102.53 (+24.54%)
$85.58 (+49.21%)
$148.14 (-13.80%)
$27.17 (+369.97%)
NUTX Analysts Opinion
NUTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating
Momentum
Momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
NUTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NUTX Street view is unimpressive and have negative views on the near-term outlook
NUTX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Low volume

High volatilty

Average key support and resistance price levels.
NUTX Earnings
The TTM data reflects the most recent 12-month period, providing overview of NUTX financial performance.
NUTX Financial Health
The company financial health has moderately improved over the past year
Financial Score
NUTX Latest Analysis
NUTX FINAL DEADLINE ALERT: Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman. SAN FRANCISCO Oct. 20 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. ) and triggering substantial losses.Hagens Berman urges Nutex investors who suffered substantial losses to . According to the complaint Nutex and HaloMD engaged in a systematic effort to exploit the insurance arbitration process. The suit claims the companies submitted
Mon Oct 20, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
NUTX Stock trends
NUTX Stock performance
NUTX Stock analysis
NUTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.